Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by lscfaon Sep 12, 2015 6:18pm
49 Views
Post# 24099258

RE:RE:RE:RE:RE:Peter hodson

RE:RE:RE:RE:RE:Peter hodsonYou are a bloody moron. If MSL's current price does not allow them to make an ACCRETIVE acquisition, they won't. A shelf prospectus is good for 2 years, you schmuck.....
Craigbad wrote: Think before you lash out Iscfa. If they need to raise $60,000,000 it would be 20,000,000 shares if the the sp was $3.00 or it will be 40,000,000 shares at $1.50 which is TWICE as dilutive. Seeing as the price is being walked down its closer to $1.50 than $3.00. The people who bought at $3.00 would be pissed at a cheaper raise unless they are selling to buy the cheap paper. Why do you think the sp is being walked down? Taking advantage of the trend to buy cheap paper imo. This will make it extremely hard to buy anything of size without a lower priced issue and bay street knows this, retail will get screwed.


<< Previous
Bullboard Posts
Next >>